Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Cleveland Clinic Rheumatology

L. Calabrese, G. Hoffman

CNS Vasculitis: Diagnostic Update

Cleveland Clinic Rheumatology

L. Calabrese

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

Pathergy in Patients with Bechet's Disease Receiving Laser Hair Remo…

Evidence-Based Hair

J. Donovan

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Great Debate (PMR/GCA) - Upfront Use of IL-6 Inhibitors

Hospital for Special Surgery

R. Spiera, P. Seo

New and Emerging Treatments in Cutaneous Vasculitis

Cleveland Clinic Rheumatology

C. Langford

Behçet Syndrome Diagnosis: How and When Do Major/Minor Clinical Mani…

Haner Direskeneli

Behcet Syndrome Update: How Does It Manifest? When Do Symptoms Typic…

Yusuf Yazici

Diagnosis of Giant Cell Arteritis

Houston Methodist DeBakey Heart and Vascular Center

S. To

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope

GCA & Steroid Weaning

RheumNow

J. Cush

When Should Biologic Agents be Introduced in Giant Cell Arteritis an…

Cleveland Clinic Rheumatology

K. Warrington

72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and…

Vanderbilt University Medical Center (VUMC)

K. Byram

Introduction to Ultrasound in Large Vessel Vasculitis - How to Corre…

University of Washington School of Medicine

W. Schmidt

GI Manifestations of Rheumatologic Disorders in Women

Jefferson Health

C. Choudhary

EADV Highlights: IgA Associated Vasculitis

Hok Bing Thio

Cleveland Clinic 2020 ACR Update on GCA: Is Tocilizumab + Ultra-Shor…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ACR Convergence 2023 Highlights: Tocilizumab vs Methotrexate in Gian…

Highlights from ACR Convergence 2023

E. Treppo

Rheumatic IO Related irAEs: Are Rheumatogists Best Equipped to Manag…

Cleveland Clinic Rheumatology

L. Calabrese